Development of antigen cross-presentation capacity in dendritic cells
- PMID: 22677187
- DOI: 10.1016/j.it.2012.04.009
Development of antigen cross-presentation capacity in dendritic cells
Abstract
Cross-presentation by dendritic cells (DCs) of exogenous antigens on MHC class I is important for the generation of immune responses to intracellular pathogens, as well as for maintenance of self tolerance. In mice, the CD8(+) DC lineage is specialised for this role. However, DCs of this lineage are not born with cross-presentation capacity. Several studies have demonstrated that it must be induced as a later developmental step by cytokines such as granulocyte macrophage colony-stimulating factor (GM-CSF), or by microbial products such as toll-like receptor (TLR) ligands. Increased cross-presentation capacity is thus induced in peripheral CD8 lineage DCs during inflammation or infection. However, this capacity is already fully developed in steady-state thymic CD8(+) DCs, in accordance with their role in the deletion of self-reactive developing T cells.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factors.Eur J Immunol. 2011 Sep;41(9):2544-55. doi: 10.1002/eji.201041374. Epub 2011 Aug 3. Eur J Immunol. 2011. PMID: 21748731
-
Macrophage-colony stimulating factor enhances MHC-restricted presentation of exogenous antigen in dendritic cells.Cytokine. 2005 Dec 7;32(5):187-93. doi: 10.1016/j.cyto.2005.08.002. Epub 2005 Nov 21. Cytokine. 2005. PMID: 16303313
-
CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].J Immunol. 2011 Feb 1;186(3):1503-11. doi: 10.4049/jimmunol.1001022. Epub 2010 Dec 27. J Immunol. 2011. PMID: 21187449
-
The CD8+ dendritic cell subset.Immunol Rev. 2010 Mar;234(1):18-31. doi: 10.1111/j.0105-2896.2009.00870.x. Immunol Rev. 2010. PMID: 20193009 Review.
-
Cytokines in the generation and maturation of dendritic cells: recent advances.Eur Cytokine Netw. 2002 Apr-Jun;13(2):186-99. Eur Cytokine Netw. 2002. PMID: 12101074 Review.
Cited by
-
Regulation of peanut-specific CD8+ T cells from nonallergic individuals.J Allergy Clin Immunol. 2021 Jan;147(1):385-387.e1. doi: 10.1016/j.jaci.2020.07.032. Epub 2020 Aug 21. J Allergy Clin Immunol. 2021. PMID: 32835695 Free PMC article.
-
Aging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8+ T Cells upon Stimulation with a TLR7 Ligand.PLoS One. 2015 Oct 16;10(10):e0140672. doi: 10.1371/journal.pone.0140672. eCollection 2015. PLoS One. 2015. PMID: 26474053 Free PMC article.
-
Plasmacytoid dendritic cells orchestrate TLR7-mediated innate and adaptive immunity for the initiation of autoimmune inflammation.Sci Rep. 2016 Apr 14;6:24477. doi: 10.1038/srep24477. Sci Rep. 2016. PMID: 27075414 Free PMC article.
-
RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells.Cell Death Differ. 2014 Dec;21(12):1825-37. doi: 10.1038/cdd.2014.96. Epub 2014 Jul 11. Cell Death Differ. 2014. PMID: 25012502 Free PMC article.
-
A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.Oncotarget. 2016 May 24;7(21):30804-19. doi: 10.18632/oncotarget.9001. Oncotarget. 2016. PMID: 27127171 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
